Motivation for treatment and recovery and resilience in patients of different ages with dysmorphophobia syndrome

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Motivation for treatment and the resilience of the patient play an important role when choosing a management strategy for body dysmorphic disorder at all stages. Psychotherapeutic techniques are most often used here, but in a large number of cases pharmacotherapy is required. Drug dosing is a challenge because therapeutically effective doses are often significantly higher than those used to effectively treat other mental disorders, creating problems with drug tolerability and suitability for treatment in the pediatric population. In this regard, it is advisable to assess the possibilities of increasing the effectiveness of psychotherapy by studying the motivation for treatment and viability of patients with body dysmorphic disorder. The study of these factors in this pathological condition is justified and justified.

Full Text

Restricted Access

About the authors

V. Voitenkov

Federal Research and Clinical Center of Infectious Diseases; Academy of postgraduate education under Federal Research and Clinical Center of Federal Biomedical Agency of Russia

Author for correspondence.
Email: longtermcare.fmba@gmail.com
ORCID iD: 0000-0003-0448-7402
SPIN-code: 6190-6930

Candidate of Medical Science, Associate Professor

Russian Federation, Saint Petersburg; Moscow

E. Bondarenko

Belgorod National Research University

Email: longtermcare.fmba@gmail.com
ORCID iD: 0009-0007-3947-6056
Russian Federation, Belgorod

A. Blinkov

National Medical Research Radiological Center, Ministry of Health of Russia

Email: longtermcare.fmba@gmail.com
SPIN-code: 3524-1942

P.A. Herzen Moscow Scientific Research Oncological, Candidate of Psychological Sciences, Associate Professor

Russian Federation, Moscow

N. Aslyamova

Belgorod National Research University

Email: longtermcare.fmba@gmail.com
ORCID iD: 0009-0003-3812-7373
SPIN-code: 3167-3147
Russian Federation, Belgorod

N. Savary

Belgorod National Research University

Email: longtermcare.fmba@gmail.com
Russian Federation, Belgorod

A. Reznik

Saint Petersburg Institute of Bioregulation and Gerontology

Email: longtermcare.fmba@gmail.com
ORCID iD: 0000-0002-4636-6978
SPIN-code: 7668-8962

Candidate of Medical Science

Russian Federation, Saint Petersburg

Е. Fesenko

Academy of postgraduate education under Federal Research and Clinical Center of Federal Biomedical Agency of Russia

Email: longtermcare.fmba@gmail.com
ORCID iD: 0000-0003-2187-5060
SPIN-code: 8131-1586

Candidate of Medical Science, Associate Professor

Russian Federation, Moscow

References

  1. Rück C., Mataix-Cols D., Feusner J.D. et al. Body dysmorphic disorder. Nat Rev Dis Primers. 2024; 10 (1): 92. doi: 10.1038/s41572-024-00577-z
  2. O'Callaghan C., Michaelian J.C., Aihara Y. et al. Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies. Lancet Regular Health Western Pacifique. 2024; 50: 101183. doi: 10.1016/j.lanwpc.2024.101183
  3. Phillips K.A., Wilhelm S., Koran L.M. et al. Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety. 2010; 27 (6): 573–91. doi: 10.1002/da.20709
  4. Чистякова Н.В., Сухорук А.А. Укрепление здоровья работников как инвестиция в трудовое долголетие. Социально значимые и особо опасные инфекционные заболевания. Мат-лы ХI Всеросс. междисцип. научно-практ. конф. с междунар. участ. Краснодар: Новация, 2024; с. 213–5 [Chistyakova N.V., Sukhoruk A.A. Improving employee health as an investment in long-term employment. Socially significant and particularly dangerous infectious diseases: Proceedings of the 11th All-Russian Interdisciplinary Scientific and Practical Conference with International Participation. Krasnodar: Novation, 2024; pp. 213–5 (in Russ.)].
  5. Kraepelin E. Psychiatrie. 8. Leipzig: JA Barth, 1909–1915.
  6. Phillips K.A., Stein D.J., Rauch S.L. et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety. 2010; 27 (6): 528–55. doi: 10.1002/da.20705
  7. Perkins A. Body dysmorphic disorder: The drive for perfection. Nursing. 2019; 49 (3): 28–33. doi: 10.1097/01.NURSE.0000553273.24557.58
  8. Chosak A., Marques L., Greenberg J.L. et al. Body dysmorphic disorder and obsessive-compulsive disorder: similarities, differences and the classification debate. Expert Rev Neurother. 2008; 8: 1209–18. doi: 10.1586/14737175.8.8.1209
  9. Rautio D., Vilaplana-Pérez A., Gumpert M. et al. Validity and reliability of the diagnostic codes for hypochondriasis and dysmorphophobia in the Swedish National Patient Register: a retrospective chart review. BMJ Open. 2021; 11 (12): e051853. doi: 10.1136/bmjopen-2021-051853
  10. Madsen S.K., Zai A., Pirnia T. et al. Cortical thickness and brain volumetric analysis in body dysmorphic disorder. Psychiatry Res. 2015; 232 (1): 115–22. doi: 10.1016/j.pscychresns.2015.02.003
  11. Grace S.A., Buchanan B.G., Maller J.J. et al. Reduced cortical thickness in body dysmorphic disorder. Psychiatry Res Neuroimaging. 2017; 259: 25–8. doi: 10.1016/j.pscychresns.2016.11.004
  12. Feusner J.D., Kurth F., Luders E. et al. Cytoarchitectonically Defined Volumes of Early Extrastriate Visual Cortex in Unmedicated Adults With Body Dysmorphic Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023; 8 (9): 909–17. doi: 10.1016/j.bpsc.2021.10.008
  13. Machremi E., Bakirtzis C., Karakasi M.V. et al. What scans see when patients see defects: neuroimaging findings in body dysmorphic disorder. J Integr Neurosci. 2022; 21 (2): 45. doi: 10.31083/j.jin2102045
  14. Lochner C., Naudé P.J.W., Stein D.J. Use of Post-mortem Brain Tissue in Investigations of Obsessive-Compulsive Disorder: A Systematic Review. Curr Neuropharmacol. 2024; 22 (5): 963–75. doi: 10.2174/1570159X21666230829145425
  15. Pikoos T.D., Malcolm A., Castle D.J. et al. A hierarchy of visual processing deficits in body dysmorphic disorder: a conceptual review and empirical investigation. Cogn Neuropsychiatry. 2024; 29 (2): 116–40. doi: 10.1080/13546805.2024.2326243
  16. Beilharz F., Castle D.J., Grace S. et al. A systematic review of visual processing and associated treatments in body dysmorphic disorder. Acta Psychiatr Scand. 2017; 136 (1): 16–36. doi: 10.1111/acps.12705
  17. Grace S.A., Toh W.L., Buchanan B. et al. Impaired Recognition of Negative Facial Emotions in Body Dysmorphic Disorder. J Int Neuropsychol Soc. 2019; 25 (8): 884–9. doi: 10.1017/S1355617719000419
  18. Wang Z., Tan Q., Frank S.M. et al. Learning of the same task subserved by substantially different mechanisms between patients with body dysmorphic disorder and healthy individuals. Cereb Cortex. 2024; 34 (5): bhae215. doi: 10.1093/cercor/bhae215
  19. Hosseini S.A., Padhy R.K. Body Image Distortion (Archived). 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025.
  20. Dong N., Nezgovorova V., Hong K. et al. Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments. Expert Opin Pharmacother. 2019; 20 (10): 1211–9. doi: 10.1080/14656566.2019.1610385
  21. Greenberg J.L., Phillips K.A., Hoeppner S.S. et al. Mechanisms of cognitive behavioral therapy vs. supportive psychotherapy in body dysmorphic disorder: An exploratory mediation analysis. Behav Res Ther. 2023; 161: 104251. doi: 10.1016/j.brat.2022.104251
  22. Wilhelm S., Phillips K.A., Greenberg J.L. et al. Efficacy and Posttreatment Effects of Therapist-Delivered Cognitive Behavioral Therapy vs Supportive Psychotherapy for Adults With Body Dysmorphic Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2019; 76 (4): 363–73. doi: 10.1001/jamapsychiatry.2018.4156
  23. Enander J., Ljótsson B., Anderhell L. et al. Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial. BMJ Open. 2019; 9 (1): e024307. doi: 10.1136/bmjopen-2018-024307
  24. Hong K., Nezgovorova V., Uzunova G, et al. Pharmacological Treatment of Body Dysmorphic Disorder. Curr Neuropharmacol. 2019; 17 (8): 697–702. doi: 10.2174/1570159X16666180426153940
  25. Постылякова Ю.В. Факторы жизнеспособности и факторы риска в образовательном пространстве вуза у студентов с разным уровнем индивидуальной жизнеспособности. Институт психологии Российской академии наук. Организационная психология и психология труда. 2024; 9 (1): 49–69 [Postylyakova, Y.V. Resilience factors and risk factors in the educational space of a university for students with different level of individual resilience. Institute of Psychology of the Russian Academy of Sciences. Organizational Psychology and Psychology of Labor. 2024; 9 (1): 49–69 (in Russ.)]. doi: 10.38098/ipran.opwp_2024_30_1_003
  26. Loscalzo Y., Giannini M., Rice K.G. Editorial: Obsessive-Compulsive Related Disorders: Towards an Advancement of the Knowledge of These Internalizing Disorders. Front Psychol. 2022; 13: 849610. doi: 10.3389/fpsyg.2022.849610
  27. Koca M., Deniz S., İnceoğlu F. The Relationship of the Psychological Resilience and Stress Coping Level of Health Personnel Working in Hospitals After Kahramanmaraş-Based Earthquakes with Traumatic Stress. Healthcare (Basel). 2025; 13 (3): 301. doi: 10.3390/healthcare13030301
  28. Mathieu A., Reignier J., Le Gouge A. et al. NUTRIREA-3 Trial Investigators; Clinical Research In Intensive Care and Sepsis (CRICS-TRIGGERSEP) Group. Resilience after severe critical illness: a prospective, multicentre, observational study (RESIREA). Crit Care. 2024; 28 (1): 237. doi: 10.1186/s13054-024-04989-x
  29. Zhang X., Lu J., Ding Z. et al. Psychological resilience and post-traumatic stress disorder as chain mediators between personality traits and cognitive functioning in patients with breast cancer. BMC Psychiatry. 2024; 24 (1): 750. doi: 10.1186/s12888-024-06219-8
  30. Iannaccone A.M., Verrusio G., Iurassich S. Discomfort and adaptation in psoriatic patients: an inchoate supportive care trial. Clin Ter. 2016; 167 (4): 105–12. doi: 10.7417/CT.2016.1939
  31. Cvitanović H., Jancić E. Influence of stressful life events on coping in psoriasis. Coll Antropol. 2014; 38 (4): 1237–40.
  32. Sandberg D.E., Gardner M., Lapham Z.K. Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025; 110 (Suppl. 1): S46-S55. doi: 10.1210/clinem/dgae668
  33. Войтенков В.Б., Дубский В.О., Леликова К.Н. и др. Мотивация к реабилитации пожилых пациентов с хроническим болевым синдромом (обзор литературы). Современные проблемы здравоохранения и медицинской статистики. 2024; 5: 332–49 [Voitenkov V.B., Dubskiy V.O., Lelikova K.N. et al. Motivation for rehabilitation of elderly patients with chronic pain syndrome (literature review). Current problems of health care and medical statistics. 2024; 5: 332–49 (in Russ.)]. doi: 10.24412/2312-2935-2024-5-332-349
  34. Mufaddel A., Osman O.T., Almugaddam F. et al. A review of body dysmorphic disorder and its presentation in different clinical settings. Prim Care Companion CNS Disord. 2013; 15 (4): 15. doi: 10.4088/PCC.12r01464
  35. Kyranou M., Karanikola M. The Long-Term Impact of Resilience-Building Interventions on Nurses: A Narrative Review of the Quantitative Evidence and Its Implications for Critical Care Nurses. Healthcare (Basel). 2025; 13 (3): 274. doi: 10.3390/healthcare13030274

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Russkiy Vrach Publishing House